Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures

Summary This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5%...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of hospital infection Vol. 92; no. 2; pp. 191 - 193
Main Authors Stewart, B.J, Gardiner, T, Perry, G.J, Tong, S.Y.C
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Summary This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5% chlorhexidine solution to 2% chlorhexidine solution. Rates of SAB episodes were calculated using registry data. Trends in SAB over time were analysed using an interrupted regression analysis. Following the change to 2% chlorhexidine, average SAB rates decreased by 68%, and it is estimated that 0.111 cases of SAB/patient-year were prevented. CVC-related SAB rates remained low throughout. These results support the use of 2% chlorhexidine in skin antisepsis for patients with AVF.
AbstractList This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5% chlorhexidine solution to 2% chlorhexidine solution. Rates of SAB episodes were calculated using registry data. Trends in SAB over time were analysed using an interrupted regression analysis. Following the change to 2% chlorhexidine, average SAB rates decreased by 68%, and it is estimated that 0.111 cases of SAB/patient-year were prevented. CVC-related SAB rates remained low throughout. These results support the use of 2% chlorhexidine in skin antisepsis for patients with AVF. References
This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5% chlorhexidine solution to 2% chlorhexidine solution. Rates of SAB episodes were calculated using registry data. Trends in SAB over time were analysed using an interrupted regression analysis. Following the change to 2% chlorhexidine, average SAB rates decreased by 68%, and it is estimated that 0.111 cases of SAB/patient-year were prevented. CVC-related SAB rates remained low throughout. These results support the use of 2% chlorhexidine in skin antisepsis for patients with AVF.
Summary This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5% chlorhexidine solution to 2% chlorhexidine solution. Rates of SAB episodes were calculated using registry data. Trends in SAB over time were analysed using an interrupted regression analysis. Following the change to 2% chlorhexidine, average SAB rates decreased by 68%, and it is estimated that 0.111 cases of SAB/patient-year were prevented. CVC-related SAB rates remained low throughout. These results support the use of 2% chlorhexidine in skin antisepsis for patients with AVF.
Author Stewart, B.J
Tong, S.Y.C
Gardiner, T
Perry, G.J
Author_xml – sequence: 1
  fullname: Stewart, B.J
– sequence: 2
  fullname: Gardiner, T
– sequence: 3
  fullname: Perry, G.J
– sequence: 4
  fullname: Tong, S.Y.C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26778135$$D View this record in MEDLINE/PubMed
BookMark eNqNks2KFDEUhYOMOD2jL-BCaumm2vxUkgqIIIN_MCA4sw_p1C07NemkTKpG-hl8aRN7dOFCXAUO37k3nHMv0FmIARB6TvCWYCJeTdtp78KWYsKLsMWUPkIbwhltqWLqDG0wUbwVEpNzdJHzhDEuOn-CzqmQsieMb9CPLzCsdnExNC40N4uZ90cfbbR2zY1ZE5RnZ-wCycDBmSaZBXJFZ7M4CEtuElhw9y58bfYFiYMz_phdbsboffxedeOr_deOODb5rrhNWFyGuXJzirb8IUF-ih6Pxmd49vBeotv3726vPrbXnz98unp73VpOuqXtiRkJGWivgIuhw7JjogNgVnUUSyUGw_BgFRCO1a5niio1cjlILEg3EsYu0cvT2LL52wp50QeXLXhvAsQ1ayIlkQz3DP8HKpjEsme8oPSE2hRzTjDqObmDSUdNsK516UnXunStq2qlrmJ68TB_3R1g-GP53U8BXp8AKHncO0g62xJ7CcyV3Bc9RPfv-W_-slvvgrPG38ER8hTXFErSmuhMNdY39WDqvZTocCeYYD8Bo2W_aQ
CitedBy_id crossref_primary_10_1016_j_infpip_2020_100037
crossref_primary_10_1016_j_jhin_2021_05_004
crossref_primary_10_1155_2017_5490963
crossref_primary_10_1093_ofid_ofaa472
crossref_primary_10_1080_23744235_2018_1501513
crossref_primary_10_1097_MCC_0000000000000754
crossref_primary_10_1007_s00134_016_4490_5
Cites_doi 10.2215/CJN.01590309
10.1038/nrneph.2011.28
10.1053/j.ajkd.2013.03.011
10.1159/000360034
10.1681/ASN.2012070643
10.1186/1471-2334-12-249
10.1046/j.1365-2710.2002.00430.x
10.1186/s12879-014-0740-8
ContentType Journal Article
Copyright The Healthcare Infection Society
2015 The Healthcare Infection Society
Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: The Healthcare Infection Society
– notice: 2015 The Healthcare Infection Society
– notice: Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ASE
FPQ
K6X
DOI 10.1016/j.jhin.2015.10.022
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
British Nursing Index
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
British Nursing Index
DatabaseTitleList British Nursing Index
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1532-2939
EndPage 193
ExternalDocumentID 10_1016_j_jhin_2015_10_022
26778135
S0195670115004636
1_s2_0_S0195670115004636
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GroupedDBID ---
--K
--M
..I
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAWTL
AAXKI
AAXUO
ABAOU
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADGUI
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ARUGR
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LUGTX
M29
M41
MHUIS
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSI
SSZ
T5K
UHS
UV1
WOW
WUQ
Z5R
ZGI
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7X8
ASE
FPQ
K6X
ID FETCH-LOGICAL-c514t-81af11d289e56d4074364ee3c9420796da30dc9e1509b839299f57d70614f133
IEDL.DBID AIKHN
ISSN 0195-6701
IngestDate Thu Oct 24 20:59:20 EDT 2024
Sat Oct 05 05:36:22 EDT 2024
Fri Dec 06 02:37:04 EST 2024
Sat Sep 28 08:04:32 EDT 2024
Fri Feb 23 02:33:27 EST 2024
Tue Oct 15 22:55:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Central venous catheter
Arteriovenous fistula
Chlorhexidine
Haemodialysis
ANZDATA
Staphylococcus aureus
Language English
License Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c514t-81af11d289e56d4074364ee3c9420796da30dc9e1509b839299f57d70614f133
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 26778135
PQID 1763707835
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_1771730830
proquest_miscellaneous_1763707835
crossref_primary_10_1016_j_jhin_2015_10_022
pubmed_primary_26778135
elsevier_sciencedirect_doi_10_1016_j_jhin_2015_10_022
elsevier_clinicalkeyesjournals_1_s2_0_S0195670115004636
PublicationCentury 2000
PublicationDate 2016-02-01
PublicationDateYYYYMMDD 2016-02-01
PublicationDate_xml – month: 02
  year: 2016
  text: 2016-02-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Journal of hospital infection
PublicationTitleAlternate J Hosp Infect
PublicationYear 2016
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Centers for Disease Control and Prevention (bib6) 2013
Betjes (bib2) 2011; 7
Crowley, Pitcher, Wilson, Guy, Fluck (bib12) 2013; 125
[last accessed January 2015].
Tong, van Hal, Einsiedel, Currie, Turnidge (bib10) 2012; 12
Australia and New Zealand Dialysis and Renal Transplant Registry. Available at
Vandecasteele, Boelaert, De Vriese (bib1) 2009; 4
Ravani, Palmer, Oliver (bib3) 2013; 24
R Core Team (bib9) 2014
Patel, Yi, Booth (bib7) 2013; 62
Centers for Disease Control and Prevention (bib5) 2011
Nielsen, Jensen-Fangel, Benfield (bib11) 2015; 15
Wagner, Soumerai, Zhang, Ross-Degnan (bib8) 2002; 27
Tong (10.1016/j.jhin.2015.10.022_bib10) 2012; 12
Crowley (10.1016/j.jhin.2015.10.022_bib12) 2013; 125
Vandecasteele (10.1016/j.jhin.2015.10.022_bib1) 2009; 4
Centers for Disease Control and Prevention (10.1016/j.jhin.2015.10.022_bib6) 2013
Patel (10.1016/j.jhin.2015.10.022_bib7) 2013; 62
Wagner (10.1016/j.jhin.2015.10.022_bib8) 2002; 27
10.1016/j.jhin.2015.10.022_bib4
Betjes (10.1016/j.jhin.2015.10.022_bib2) 2011; 7
R Core Team (10.1016/j.jhin.2015.10.022_bib9) 2014
Centers for Disease Control and Prevention (10.1016/j.jhin.2015.10.022_bib5) 2011
Nielsen (10.1016/j.jhin.2015.10.022_bib11) 2015; 15
Ravani (10.1016/j.jhin.2015.10.022_bib3) 2013; 24
References_xml – year: 2013
  ident: bib6
  article-title: Dialysis Bloodstream Infection (BSI) Prevention Collaborative
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 27
  start-page: 299
  year: 2002
  end-page: 309
  ident: bib8
  article-title: Segmented regression analysis of interrupted time series studies in medication use research
  publication-title: J Clin Pharm Ther
  contributor:
    fullname: Ross-Degnan
– volume: 12
  start-page: 249
  year: 2012
  ident: bib10
  article-title: Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis. Impact of ethnicity and socioeconomic status on
  publication-title: BMC Infect Dis
  contributor:
    fullname: Turnidge
– year: 2014
  ident: bib9
  article-title: R: a language and environment for statistical computing
  contributor:
    fullname: R Core Team
– volume: 125
  start-page: 295
  year: 2013
  end-page: 308
  ident: bib12
  article-title: UK Renal Registry 16th annual report: Chapter 15. Epidemiology of reported infections amongst patients receiving dialysis for established renal failure in England from May 2011 to April 2012: a joint report from Public Health England and the UK Renal Registry
  publication-title: Nephron Clin Pract
  contributor:
    fullname: Fluck
– year: 2011
  ident: bib5
  article-title: 2011 Guidelines for the prevention of intravascular catheter-related infections
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 62
  start-page: 322
  year: 2013
  end-page: 330
  ident: bib7
  article-title: Bloodstream infection rates in outpatient haemodialysis facilities participating in a collaborative prevention effort: a quality improvement report
  publication-title: Am J Kidney Dis
  contributor:
    fullname: Booth
– volume: 15
  start-page: 6
  year: 2015
  ident: bib11
  article-title: Risk and prognosis of
  publication-title: BMC Infect Dis
  contributor:
    fullname: Benfield
– volume: 7
  start-page: 257
  year: 2011
  end-page: 265
  ident: bib2
  article-title: Prevention of catheter-related bloodstream infection in patients on haemodialysis
  publication-title: Nat Rev Nephrol
  contributor:
    fullname: Betjes
– volume: 24
  start-page: 465
  year: 2013
  end-page: 473
  ident: bib3
  article-title: Associations between haemodialysis access type and clinical outcomes: a systematic review
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Oliver
– volume: 4
  start-page: 1388
  year: 2009
  end-page: 1400
  ident: bib1
  article-title: infections in haemodialysis: what a nephrologist should know
  publication-title: Clin J Am Soc Nephrol
  contributor:
    fullname: De Vriese
– volume: 4
  start-page: 1388
  year: 2009
  ident: 10.1016/j.jhin.2015.10.022_bib1
  article-title: Staphylococcus aureus infections in haemodialysis: what a nephrologist should know
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01590309
  contributor:
    fullname: Vandecasteele
– volume: 7
  start-page: 257
  year: 2011
  ident: 10.1016/j.jhin.2015.10.022_bib2
  article-title: Prevention of catheter-related bloodstream infection in patients on haemodialysis
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2011.28
  contributor:
    fullname: Betjes
– volume: 62
  start-page: 322
  year: 2013
  ident: 10.1016/j.jhin.2015.10.022_bib7
  article-title: Bloodstream infection rates in outpatient haemodialysis facilities participating in a collaborative prevention effort: a quality improvement report
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2013.03.011
  contributor:
    fullname: Patel
– volume: 125
  start-page: 295
  year: 2013
  ident: 10.1016/j.jhin.2015.10.022_bib12
  publication-title: Nephron Clin Pract
  doi: 10.1159/000360034
  contributor:
    fullname: Crowley
– volume: 24
  start-page: 465
  year: 2013
  ident: 10.1016/j.jhin.2015.10.022_bib3
  article-title: Associations between haemodialysis access type and clinical outcomes: a systematic review
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2012070643
  contributor:
    fullname: Ravani
– ident: 10.1016/j.jhin.2015.10.022_bib4
– year: 2014
  ident: 10.1016/j.jhin.2015.10.022_bib9
  contributor:
    fullname: R Core Team
– year: 2011
  ident: 10.1016/j.jhin.2015.10.022_bib5
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 12
  start-page: 249
  year: 2012
  ident: 10.1016/j.jhin.2015.10.022_bib10
  article-title: Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis. Impact of ethnicity and socioeconomic status on Staphylococcus aureus bacteraemia incidence and mortality: a heavy burden in indigenous Australians
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-12-249
  contributor:
    fullname: Tong
– year: 2013
  ident: 10.1016/j.jhin.2015.10.022_bib6
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 27
  start-page: 299
  year: 2002
  ident: 10.1016/j.jhin.2015.10.022_bib8
  article-title: Segmented regression analysis of interrupted time series studies in medication use research
  publication-title: J Clin Pharm Ther
  doi: 10.1046/j.1365-2710.2002.00430.x
  contributor:
    fullname: Wagner
– volume: 15
  start-page: 6
  year: 2015
  ident: 10.1016/j.jhin.2015.10.022_bib11
  article-title: Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-014-0740-8
  contributor:
    fullname: Nielsen
SSID ssj0009395
Score 2.2406812
Snippet Summary This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a...
This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 191
SubjectTerms Anti-Infective Agents, Local - administration & dosage
Antisepsis - methods
ANZDATA
Arteriovenous fistula
Australia - epidemiology
Bacteremia - epidemiology
Bacteremia - microbiology
Bacteremia - prevention & control
Catheter-Related Infections - epidemiology
Catheter-Related Infections - microbiology
Catheter-Related Infections - prevention & control
Central venous catheter
Chlorhexidine
Chlorhexidine - administration & dosage
Haemodialysis
Hospitals
Humans
Infectious Disease
Renal Dialysis - adverse effects
Retrospective Studies
Skin - microbiology
Staphylococcal Infections - epidemiology
Staphylococcal Infections - microbiology
Staphylococcal Infections - prevention & control
Staphylococcus aureus
Staphylococcus aureus - isolation & purification
Title Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0195670115004636
https://dx.doi.org/10.1016/j.jhin.2015.10.022
https://www.ncbi.nlm.nih.gov/pubmed/26778135
https://search.proquest.com/docview/1763707835
https://search.proquest.com/docview/1771730830
Volume 92
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwEB3BcqlUVW2h7VKKXIlbFTZO4oQcVwi07aocgApuluPYIouarPCueuMH-tOdcRxQVcGhJyuWLTsz45mxPfMMcKBNjbuSxEZloqooK_M6OlJxGlWisLnO8oz7596-n-WzH9m3a3G9AcdDLgyFVQbd3-t0r61DzSRQc7JsmsmFT3UrvEvjYa82YQvNEd3Vbk2_zmdnj9i7aSmGZwmpQ8id6cO8FjcNwaBycUhBXknylH16yv_0duj0NbwKDiSb9nN8AxumfQsv-9M31icVbcPvc0JkJZqzpmXoUCIx0Wp1Wq8dU-s7g0XlcZqV-dkoRngRjpoGmFXHkCimocMGdoNNOkovIewSZlFuul9U7-_ZPV9ZZ5m7xd7IpcaZJbXzhrHGkdwOXJ6eXB7PovDsQqTRe1pFR1xZzmvciRmRIyfRx8gzY1JdZklcIDdVGte6NEj3svL-VWlFURe0t7S45X0Ho7ZrzQdgVlmDQmKVsjbDAvtqoXludFFaK7IxfBloLZc9uIYcos4WkjgjiTNUh5wZQzGwQw5po6jojAurzkkuXSJj-Y9kjEE89PxLuCTajWdH_DxwXeKqo6sU1ZpujSOhWiacpFQ814YiHNDFjcfwvheZh79MCLePp2L3P2f2EV7gVwgf34PR6m5tPqF3tKr2YfPwnu-HNUDl_Pxq_gekOBNH
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5ROLQSqkofsLSlrtRbFTYPO8HHChUtLXBotxI3y3FsEaomK7wrbvwB_nRnHIeqquDQUyRnLCcz4_HnZOYzwAdjG9yV5C6Rua4TLssmOdBpkdSicqXhJc_CcW-nZ-XsB_9yLs7X4HCshaG0yhj7h5geonVsmUZtThdtO_0eSt2qAGkC7dUj2OAC0S869f7NnzwPWUgxHkpI4rFyZkjyurxoiQQ1E_uU4pXn961O96HPsAodPYOnET6yT8MTbsGa7Z7D5vDtjQ0lRS_g9hvxsZLGWdsxhJOoSlyzemNWnunVlcVLHViatf3VakZsEZ5EI8mqZ6gS29KnBnaBIj0VlxBzCXPoNf01tYe_7MGqrHfM_8TeaKPW2wXJhWWxwZH8S5gffZ4fzpJ46EJiEDstk4NMuyxrcB9mRYl2RIRRcmsLI3meVmhLXaSNkRa1LuuArqQTVVPRztLhhvcVrHd9Z3eAOe0suojT2jmOF-xrhMlKayrpnOAT-DjqWi0Gag015pxdKrKMIstQG1pmAtVoDjUWjWKYsz7OOa8y5XOVqn_8YgLirudfrqVw1XhwxPej1RXOOfqRojvbr3AkDMrEklSIh2QovwEBbjqB7cFl7t4yJ9a-rBC7__lk7-DxbH56ok6Oz76-hid4JyaSv4H15dXKvkWctKz3wjz4DZaUEn0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduction+in+Staphylococcus+aureus+bacteraemia+rates+in+patients+receiving+haemodialysis+following+alteration+of+skin+antisepsis+procedures&rft.jtitle=The+Journal+of+hospital+infection&rft.au=Stewart%2C+B.J&rft.au=Gardiner%2C+T&rft.au=Perry%2C+G.J&rft.au=Tong%2C+S.Y.C&rft.date=2016-02-01&rft.issn=0195-6701&rft.volume=92&rft.issue=2&rft.spage=191&rft.epage=193&rft_id=info:doi/10.1016%2Fj.jhin.2015.10.022&rft.externalDBID=ECK1-s2.0-S0195670115004636&rft.externalDocID=1_s2_0_S0195670115004636
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01956701%2FS0195670115X00156%2Fcov150h.gif